• No results found

FORMULATION OF OLMESARTAN BY SURFACE MODIFICATION TECHNOLOGY FOR ENHANCING THE SOLUBILITY AND DISSOLUTION PROPERTIES

N/A
N/A
Protected

Academic year: 2020

Share "FORMULATION OF OLMESARTAN BY SURFACE MODIFICATION TECHNOLOGY FOR ENHANCING THE SOLUBILITY AND DISSOLUTION PROPERTIES"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1: Phase solubility analysis using modified porous starch as a carrier
Figure 1: Phase solubility analysis using modified porous starch as a carrier
Figure 2: FTIR of pure drug
Figure 4: DSC of Olmesartan
+4

References

Related documents

Table 7.3 Parametric data analysis for extracellular alkalosis study 172.. Table 7.4 Parametric data analysis for normocapnie study

When these nations were divided into three groups, the median (range) HIV prevalence estimates remained constant at 0.7% (0.05 – 33.7%) and 0.75% (0.05% – 33.4%) for the lower

[ 9 , 10 ] In our current study, we sought to evaluate continuous bladder irrigation with isotonic (0.9% NaCl) normal saline (CBSI) for two hours following TURBT as a strategy to

We assume that, at the bank default time τ, an exceptional (e.g. operational) loss occurs and wipes out any residual risk capital (shareholder capital at risk and risk margin)

Discussion: Strategies that support IPCPs in developing their writing skills may encourage more IPCPs to disseminate evidence to support best practice by publishing their work in

Individualizing Care for Pediatric Patients with Autism Spectrum Disorder in Perioperative Services..

national regulations of the Contracting Parties with respect to entry, stay and departure of foreigners shall remain in force in the territories of the Contracting Parties.

• Medizinische Daten: Wirkstoffgruppen und -kombinationen der Ersttherapie, Dauer der Ersttherapie bis zum Wechsel in Monaten, Zeitpunkt der Umstellung, Wirk-